132.3 USD
+2.24 (+1.72%)
133.3 USD
+1 (+0.76%)
Overall WGS gets a fundamental rating of 5 out of 10. We evaluated WGS against 101 industry peers in the Health Care Providers & Services industry. WGS has a great financial health rating, but its profitability evaluates not so good. WGS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
WGS had positive earnings in the past year.
WGS had a positive operating cash flow in the past year.
WGS had negative earnings in each of the past 5 years.
In the past 5 years WGS always reported negative operating cash flow.
1.2 Ratios
WGS's Return On Assets of 0.42% is in line compared to the rest of the industry. WGS outperforms 50.49% of its industry peers.
With a Return On Equity value of 0.71%, WGS perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
WGS has a Return On Invested Capital (1.94%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROIC | 1.94% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.52%, WGS is in line with its industry, outperforming 52.48% of the companies in the same industry.
With a Operating Margin value of 2.48%, WGS perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
Looking at the Gross Margin, with a value of 69.65%, WGS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
In the last couple of years the Gross Margin of WGS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
WGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
WGS has more shares outstanding than it did 1 year ago.
WGS has more shares outstanding than it did 5 years ago.
WGS has a better debt/assets ratio than last year.
2.2 Solvency
WGS has an Altman-Z score of 8.78. This indicates that WGS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.78, WGS belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
The Debt to FCF ratio of WGS is 3.37, which is a good value as it means it would take WGS, 3.37 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.37, WGS is doing good in the industry, outperforming 73.27% of the companies in the same industry.
WGS has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
WGS's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. WGS outperforms 72.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Altman-Z | 8.78 |
ROIC/WACC0.21
WACC9.02%
2.3 Liquidity
WGS has a Current Ratio of 2.71. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of WGS (2.71) is better than 83.17% of its industry peers.
WGS has a Quick Ratio of 2.59. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Quick ratio of 2.59. This is amongst the best in the industry. WGS outperforms 83.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 274.07% over the past year.
The Revenue has grown by 50.50% in the past year. This is a very strong growth!
WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.26% yearly.
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
3.2 Future
The Earnings Per Share is expected to grow by 79.55% on average over the next years. This is a very strong growth
WGS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.73% yearly.
EPS Next Y506%
EPS Next 2Y52.56%
EPS Next 3Y94.22%
EPS Next 5Y79.55%
Revenue Next Year47.11%
Revenue Next 2Y34.8%
Revenue Next 3Y29.85%
Revenue Next 5Y26.73%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 70.37 indicates a quite expensive valuation of WGS.
WGS's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of WGS to the average of the S&P500 Index (26.60), we can say WGS is valued expensively.
Based on the Price/Forward Earnings ratio of 247.15, the valuation of WGS can be described as expensive.
WGS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. WGS is more expensive than 61.39% of the companies in the same industry.
WGS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.37 | ||
| Fwd PE | 247.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WGS is valued a bit more expensive than the industry average as 64.36% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 60.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 244.33 | ||
| EV/EBITDA | 106.73 |
4.3 Compensation for Growth
WGS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WGS's earnings are expected to grow with 94.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y52.56%
EPS Next 3Y94.22%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
132.3
+2.24 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.08%
Inst Owner Change0%
Ins Owners1.54%
Ins Owner Change0.02%
Market Cap3.82B
Revenue(TTM)402.19M
Net Income(TTM)2.08M
Analysts83.08
Price Target167.51 (26.61%)
Short Float %13.35%
Short Ratio6.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)200.04%
Min EPS beat(2)14.73%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)260.69%
Min EPS beat(4)14.73%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)161.06%
EPS beat(12)9
Avg EPS beat(12)102.92%
EPS beat(16)12
Avg EPS beat(16)78.7%
Revenue beat(2)2
Avg Revenue beat(2)14.71%
Min Revenue beat(2)10.43%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)12.86%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)13.89%
Revenue beat(12)11
Avg Revenue beat(12)9.25%
Revenue beat(16)14
Avg Revenue beat(16)5.95%
PT rev (1m)3.65%
PT rev (3m)32.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.37 | ||
| Fwd PE | 247.15 | ||
| P/S | 9.51 | ||
| P/FCF | 244.33 | ||
| P/OCF | 114.58 | ||
| P/B | 13.08 | ||
| P/tB | 35.78 | ||
| EV/EBITDA | 106.73 |
EPS(TTM)1.88
EY1.42%
EPS(NY)0.54
Fwd EY0.4%
FCF(TTM)0.54
FCFY0.41%
OCF(TTM)1.15
OCFY0.87%
SpS13.92
BVpS10.11
TBVpS3.7
PEG (NY)0.14
PEG (5Y)N/A
Graham Number20.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROCE | 2.45% | ||
| ROIC | 1.94% | ||
| ROICexc | 3.13% | ||
| ROICexgc | 11.96% | ||
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% | ||
| FCFM | 3.89% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 72.79% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 1.83 | ||
| Cash Conversion | 97.25% | ||
| Profit Quality | 750.55% | ||
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 8.78 |
F-Score8
WACC9.02%
ROIC/WACC0.21
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
EPS Next Y506%
EPS Next 2Y52.56%
EPS Next 3Y94.22%
EPS Next 5Y79.55%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
Revenue Next Year47.11%
Revenue Next 2Y34.8%
Revenue Next 3Y29.85%
Revenue Next 5Y26.73%
EBIT growth 1Y117.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year534.85%
EBIT Next 3Y123%
EBIT Next 5YN/A
FCF growth 1Y107.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.52%
OCF growth 3YN/A
OCF growth 5YN/A
GENEDX HOLDINGS CORP / WGS FAQ
Can you provide the ChartMill fundamental rating for GENEDX HOLDINGS CORP?
ChartMill assigns a fundamental rating of 5 / 10 to WGS.
What is the valuation status for WGS stock?
ChartMill assigns a valuation rating of 2 / 10 to GENEDX HOLDINGS CORP (WGS). This can be considered as Overvalued.
What is the profitability of WGS stock?
GENEDX HOLDINGS CORP (WGS) has a profitability rating of 3 / 10.
What is the valuation of GENEDX HOLDINGS CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GENEDX HOLDINGS CORP (WGS) is 70.37 and the Price/Book (PB) ratio is 13.08.
What is the financial health of GENEDX HOLDINGS CORP (WGS) stock?
The financial health rating of GENEDX HOLDINGS CORP (WGS) is 7 / 10.